Cormorant Asset Management’s Aardvark Therapeutics, Inc. Common Stock AARD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.8M Hold
800,189
0.81% 27
2025
Q1
$6.01M Buy
+800,189
New +$6.01M 0.45% 36